AI주식인사이트AI Stock Insight
C

내츄럴엔도텍

168330KOSDAQ자연과학 및 공학 연구개발업

41.5 / 100

Reference Date: 2026-04-13

Financial Score16.0 / 40
News Sentiment12.5 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is undervalued vs. peers but the high debt ratio poses financial risk. Declined 10.8% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Naturalendo Tech develops health supplements and cosmeceuticals using natural resources and biotechnology, focusing on anti-aging and health promotion. Through its subsidiary Endoderma, the company researches and produces micro-needle patches based on transdermal drug delivery systems (TDDS). Key products include 'Snut Wonder' for menopausal women and the 'NEEDLY' skincare line, with future goals including global market expansion and enhanced ESG practices.

Number of Employees

83people

Average Salary

49.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 120.074.0Point
PBR
3.18Industry Average 3.824.0Point

In line with industry avg

ROE
-14.45Industry Average -32.113.5Point

Well below industry avg

Debt Ratio
30.13Industry Average 7.520.0Point

4.0x industry avg (risky)

Trend 2023~20254.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲9.2% (2-year basis)

Operating Profit Growth Rate
2.5 / 3

Avg ▲10.1% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -15.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (12%, downtrend)

Current 2,325Won52-week high 5,50052-week low 1,858
1-month return1.0Point

1m -10.75% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral정기주주총회결과2026-03-24
  • Neutral감사보고서제출2026-03-16
  • Neutral사업보고서 (2025.12)2026-03-16